Key Takeaways
- • Quartzy secured $23 million in financing from Avenue Capital Group and BroadOak Capital Partners, marking a significant capital infusion for the vertically-integrated life sciences procurement platform.
- • The company serves more than 3,000 organizations across academic research labs, biotech startups, pharmaceutical companies, and healthcare institutions, positioning it as a market leader in lab management and supply ordering.
- • Funding will be deployed toward software platform enhancement, expansion of the supplier network, customer experience improvements, and go-to-market capabilities—indicating strategic focus on platform consolidation and market penetration.
- • Quartzy operates a dual-model business combining software-as-a-service (lab management platform) with a marketplace (Quartzy Shop) for life sciences supplies, creating integrated procurement workflows from requisition through inventory management.
- • Founded in 2009 by Adam Regelmann (Founder/CPO) and Jayant Kulkarni (Founder/CEO), Quartzy is based in Hayward, California, and operates as a private company with institutional backing from leading alternative asset managers.
Summary
Quartzy, a vertically-integrated procurement platform serving the life sciences sector, announced it has closed a $23 million financing round led by Avenue Capital Group and BroadOak Capital Partners. The capital raise reflects investor confidence in the company's business model and market positioning within a fragmented procurement landscape for research and laboratory organizations.
The company operates at the intersection of software and marketplace services. Its platform centralizes lab management operations, enabling teams to track orders, manage inventory, and streamline procurement workflows. The Quartzy Shop component provides direct access to a curated supplier network, allowing organizations to consolidate purchasing and reduce operational friction. This integrated approach differentiates the platform from point solutions focused solely on inventory management or ordering logistics.
Quartzy's customer base spans more than 3,000 organizations, including academic research institutions, early-stage biotech companies, established pharmaceutical firms, and healthcare systems. This diversified user base across the research and commercial life sciences ecosystems provides revenue stability and cross-selling opportunities. The breadth of adoption suggests strong product-market fit within the target segment.
The $23 million capital deployment will be directed toward platform development, supplier network expansion, customer experience enhancement, and sales and marketing capabilities. This allocation suggests management prioritizes deepening platform functionality, expanding procurement relationships with life sciences suppliers, and scaling customer acquisition—typical objectives for B2B SaaS platforms in growth phases.
Founded in 2009, Quartzy was established by Adam Regelmann and Jayant Kulkarni. The company operates from Hayward, California, and maintains a team of 51–200 employees. The involvement of Avenue Capital Group and BroadOak Capital Partners—both experienced institutional investors in software and life sciences infrastructure—signals confidence in the company's long-term growth trajectory and market opportunity within laboratory and research procurement automation.
The company operates at the intersection of software and marketplace services. Its platform centralizes lab management operations, enabling teams to track orders, manage inventory, and streamline procurement workflows. The Quartzy Shop component provides direct access to a curated supplier network, allowing organizations to consolidate purchasing and reduce operational friction. This integrated approach differentiates the platform from point solutions focused solely on inventory management or ordering logistics.
Quartzy's customer base spans more than 3,000 organizations, including academic research institutions, early-stage biotech companies, established pharmaceutical firms, and healthcare systems. This diversified user base across the research and commercial life sciences ecosystems provides revenue stability and cross-selling opportunities. The breadth of adoption suggests strong product-market fit within the target segment.
The $23 million capital deployment will be directed toward platform development, supplier network expansion, customer experience enhancement, and sales and marketing capabilities. This allocation suggests management prioritizes deepening platform functionality, expanding procurement relationships with life sciences suppliers, and scaling customer acquisition—typical objectives for B2B SaaS platforms in growth phases.
Founded in 2009, Quartzy was established by Adam Regelmann and Jayant Kulkarni. The company operates from Hayward, California, and maintains a team of 51–200 employees. The involvement of Avenue Capital Group and BroadOak Capital Partners—both experienced institutional investors in software and life sciences infrastructure—signals confidence in the company's long-term growth trajectory and market opportunity within laboratory and research procurement automation.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.